Cian Healthcare opened higher at ₹39.19, compared with its previous close of ₹38.43. In the last trading session on 12 Nov 2026, the stock traded between ₹39.19 and ₹39.19, with an average traded price of ₹39.19. It showed an upward intraday trend.
An investment of ₹10,000 made 1 year ago in Cian Healthcare is now worth
₹ 35,498.00
Giving a profit of
₹ 25,498.00 (254.98%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.76 (+1.98%)
Day High
₹39.19
Day Low
₹39.19
Day Open
₹39.19
Prev Close
₹38.43
Volume
274
Value Traded
₹0.00 Cr
1W Return
12.52%
1M Return
51.02%
3M Return
254.98%
6M Return
254.98%
1Y Return
254.98%
Market Cap (₹ Cr.)
98
PE Ratio
-4.10
PB Ratio
11.26
Dividend Yield
-
ROE
-272.88%
ROCE
-70.88%
Book Value (₹)
3.41
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
12.52%
6 Weeks
-
1 Month
51.02%
3 Months
254.98%
9 Months
254.98%
Cian Healthcare approves ESOP scheme 2026, adopts FY26 financials
Cian Healthcare approved the Employee Stock Option Scheme, 2026, via special resolution at its 23rd AGM. Shareholders adopted the audited standalone and consolidated financial statements for FY26. Rasool Singhal & Co. was appointed as statutory auditors, filling a casual vacancy. Promoters abstained from voting on the re-appointment of Mr. Pradeep Kumar Jain due to interest. All six resolutions passed with 100% support from votes polled by participating shareholders.
1mo agoCian Healthcare provides web link for 23rd AGM notice and FY26 annual report
Cian Healthcare provides web link for 23rd AGM notice and FY26 Annual Report. AGM scheduled for September 29, 2026, via VC/OAVM with e-voting from September 26. M/s Rasool Singhal & Co appointed as statutory auditor effective September 2, 2026. Board recommends Employee Stock Option Scheme 2026 for up to 1 crore options.
2mo agoCian Healthcare audit committee notes statutory auditor resignation
Cian Healthcare’s Audit Committee noted the resignation of statutory auditors M/s S S R C A & Co. The resignation is effective from August 27, 2026, with no material concerns cited by the Committee. The disclosure complies with SEBI Listing Regulations and relevant master circulars. The matter has been recommended to the Board of Directors for deliberation.
2mo agoCian Healthcare shareholders approve all resolutions via postal ballot
Cian Healthcare Limited shareholders approved all nine resolutions via remote e-voting, including related party transactions and leadership appointments. The voting concluded on July 09, 2026, with over 99% support for key proposals.
4mo agoCian Healthcare publishes postal ballot notice for shareholder approvals
Cian Healthcare has published its postal ballot notice to seek shareholder approval for material related party transactions and the appointment of a Managing Director and a Woman Non-Executive Director. The remote e-voting process is scheduled from June 10, 2026, to July 9, 2026, with a record date of June 5, 2026. Resolutions include transactions worth ₹114.56 crore, borrowing limits up to ₹100 crore, and director appointments.
5mo agoCian Healthcare board to consider FY26 results on May 30
Cian Healthcare Limited's board will meet on May 30, 2026, to approve audited financial results for FY26 and the half year ended March 31, 2026. The trading window is closed for designated persons until 48 hours post-result declaration.
5mo agoNo similar stocks data available.
An investment of ₹10,000 made 1 year ago in Cian Healthcare is now worth
₹ 35,498.00
Giving a profit of
₹ 25,498.00 (254.98%)
Note: Past profits do not guarantee future returns.